BibTex RIS Kaynak Göster

Studies on imidazopyridine derivatives as acetylcholinesterase inhibitors

Yıl 2012, Cilt: 2 Sayı: 3, 119 - 123, 30.01.2014

Öz

Objective: In this study we aimed to synthesize some hydrazide derivatives of imidazo[1,2-a]pyridine and to evaluate their anti-cholinesterase activities. 

Method: The reaction of imidazo[1,2-a]pyridine-2-carboxylic acid hydrazides with various benzaldehydes gave N-(benzylidene)imidazo[1,2-a]pyridine-2-carboxylic acid hydrazide derivatives. The chemical structures of the compounds were elucidated by IR, 1H-NMR, FAB+-MS spectral data and elemental analysis. In the pharmacological study, anti-cholinesterase activities of these compounds have been evaluated by using modified Ellman’s spectrophotometric method.

Results: Three of the synthesized compounds (2, 3 and 4) can be identified as promising anticholinesterase agents due to their inhibitory effect on AChE with IC50 value of 74.42±4.29, 43.26±7.28 and 18.29±2.31 μM, respectively when compared with Donepezil (IC50=0.058±0.002 μM).

Conclusion: The halogen substitutions on phenyl ring have a crucial influence on anticholinesterase activity.


Key words: Imidazo[1,2-a]pyridine, hydrazone, cholinesterase inhibitors

Kaynakça

  • Campbell NA, Reece JB. Biology. 6th ed. San Francisco: Pearson Education Inc; 2002. pp. 1037.
  • Jones BE. From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci. 2005; 26(11): 578-586.
  • Ehrenstein G, Galdzicki Z, Lange GD. The choline-leakage hypothesis for the loss of acetylcholine in Alzheimer’s disease. Biophys J. 1997; 73(3): 1276-1280.
  • Parnetti L, Senin U, Mecocci P. Cognitive enhancement therapy for Alzheimer’s disease. Drugs. 1997; 53: 752-768.
  • Brinton RD, Yamazaki RS. Advances and challenges in the prevention and treatment of Alzeimer’s Disease. Pharmaceut Res. 1998; 15: 386- 398.
  • Corinne B, Ooms F, Carrupt P, Testa B, Catto M, Leonetti F, Altomare C, Carotti A. Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase. J Med Chem. 2000; 44: 3195-3198.
  • Castro A, Martinez A. Peripheral and dual binding site acetylcholinesterase inhibitors: Implications in treatment of Alzheimer’s disease. Mini-Rev Med Chem. 2001; 1: 267-272.
  • Utku S, Gökçe M, Orhan I, Sahin MF. Synthesis of novel 6-substituted 3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro. Arznei-forschung. 2011; 61(1): 1-7.
  • Alptüzün V, Prinz M, Hörr V, Scheiber J, Radacki K, Fallarero A, Vuorela P, Engels B, Braunschweig H, Erciyas E, Holzgrabe U. Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with beta-amyloid, acetylcholine, and butyrylcholine esterases. Bioorg Med Chem. 2010; 18(5): 2049-2059.
  • Gwaram NS, Ali HM, Abdulla MA, Buckle MJC, Sukumaran SD, Chung LY, Othman R, Alhadi AA, Yehye WA, Hadi AHA, Hassandarvish P, Khaledi H, Abdelwahab SI. Synthesis, characterization, X-ray crystallography, acetyl cholinesterase inhibition and antioxidant activities of some novel ketone derivatives of gallic hydrazide- derived schiff bases. Molecules. 2012; 17: 2408-2427.
  • Özçelik AB, Gökçe M, Orhan I, Kaynak F, Sahin MF. Synthesis and antimicrobial, acetylcholinesterase and butyrylcholinesterase inhibitory activities of novel ester and hydrazide derivatives of 3(2H)-pyridazinone. Arznei-forschung. 2010; 60(7): 452-458.
  • Bunyapaiboonsri T, Ramström O, Lohmann S, Lehn SM, Peng L, Goeldner M. Dynamic deconvolution of a pre-equilibrated dynamic combinatorial library of acetylcholinesterase inhibitors. Chembiochem. 2001; 2: 438-444.
  • Gholivand K, Hosseini Z, Farshadian S, Naderi-Manesh H. Synthesis, characterization, oxidative degradation, antibacterial activity and acetylcholinesterase/butyrylcholinesterase inhibitory effects of some new phosphorus (V) hydrazides. Eur J Med Chem. 2010; 45(11): 5130- 5139.
  • Elsinghorst PW, Tanarro CMG, Gutschow M. Novel heterobivalent tacrine derivatives as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase. J Med Chem. 2006; 49: 7540-7544.
  • Szymański P, Zurek E, Mikiciuk-Olasik E. New tacrine- hydrazinonicotinamide hybrids as acetylcholinesterase inhibitors of potential interest for the early diagnostics of Alzheimer’s disease. Pharmazie. 2006; 61(4): 269-273.
  • Yale HL, Losen K, Martins J, Holsing M, Perry MF, Bernstein J. Chemotherapy of Experimental Tuberculosis. VIII. The synthesis of acid hydrazides, their derivatives and related compound. J Am Chem Soc. 1953; 75: 1933-1942.
  • Bukowski L, Janowiec M. 1-Methyl-1H-2-imidazo[4,5-b]
  • pyridinecarboxylic acid and of its derivatives with suspected antituberculotic activity. Pharmazie. 1996; 51: 27-30.
  • Kaplancıklı ZA, Turan-Zitouni G, Özdemir A, Revial G. Synthesis and anticandidal activity of some imidazopyridine derivatives. J Enzym Inhib Med Chem. 2008; 23(6): 866-870.
  • Perry NSL, Houghton PJ, Theobald AE, Jenner P, Perry EK. In-vitro inhibition of human erythrocyte acetylcholine esterase by Salvia lavandulae folia essential oil and constituent terpenes. J Pharm Pharmacol. 2000; 52: 895-902.
  • Ellman GL, Courtney KD, Andres V, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961; 7: 88-95.

Asetilkolinesteraz inhibitörleri olarak imidazopiridin türevleri üzerine çalışmalar

Yıl 2012, Cilt: 2 Sayı: 3, 119 - 123, 30.01.2014

Öz

Amaç: Bu çalışmada, imidazo[1,2-a]piridinin bazı hidrazid türevlerinin sentezlenmesi ve antikolinesteraz aktivitelerinin araştırılması amaçlandı. 

Yöntem: İmidazo[1,2-a]piridin-2-karboksilik asid hidrazidi ile çeşitli benzaldehit türevlerinin reaksiyonu ile hedef bileşikler olan N-(benziliden)imidazo[1,2-a]piridin-2-karboksilik asid hidrazid türevlerine ulaşıldı. Bileşiklerin kimyasal yapıları, IR, 1H-NMR ve FAB+-MS spektral verileri ve elementel analiz verileri ile aydınlatıldı. Modifiye edilmiş Ellman spektrofotometrik metodu kullanılarak, elde edilen tüm bileşiklerin asetilkolinesteraz (AChE) inhibisyonları incelendi.

Bulgular: Donepezil (IC50=0.058±0.002 μM) ile kıyaslandığında, sentezlenen bileşiklerin üç tanesinin (2, 3 ve 4), IC50 değerleri sırasıyla 74.42±4.29, 43.26±7.28 ve 18.29±2.31 μM olarak ölçülmüş ve AChE üzerinde ümit verici inhibisyonları gözlenmiştir.

Sonuçlar: Fenil halkası üzerindeki halojen sübstitisyonunun, antikolinesteraz etki üzerinde önemli katkısı vardır.


Anahtar Kelimeler : İmidazo[1,2-a]piridin, hidrazon, kolinesteraz inhibitörleri

Kaynakça

  • Campbell NA, Reece JB. Biology. 6th ed. San Francisco: Pearson Education Inc; 2002. pp. 1037.
  • Jones BE. From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci. 2005; 26(11): 578-586.
  • Ehrenstein G, Galdzicki Z, Lange GD. The choline-leakage hypothesis for the loss of acetylcholine in Alzheimer’s disease. Biophys J. 1997; 73(3): 1276-1280.
  • Parnetti L, Senin U, Mecocci P. Cognitive enhancement therapy for Alzheimer’s disease. Drugs. 1997; 53: 752-768.
  • Brinton RD, Yamazaki RS. Advances and challenges in the prevention and treatment of Alzeimer’s Disease. Pharmaceut Res. 1998; 15: 386- 398.
  • Corinne B, Ooms F, Carrupt P, Testa B, Catto M, Leonetti F, Altomare C, Carotti A. Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase. J Med Chem. 2000; 44: 3195-3198.
  • Castro A, Martinez A. Peripheral and dual binding site acetylcholinesterase inhibitors: Implications in treatment of Alzheimer’s disease. Mini-Rev Med Chem. 2001; 1: 267-272.
  • Utku S, Gökçe M, Orhan I, Sahin MF. Synthesis of novel 6-substituted 3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro. Arznei-forschung. 2011; 61(1): 1-7.
  • Alptüzün V, Prinz M, Hörr V, Scheiber J, Radacki K, Fallarero A, Vuorela P, Engels B, Braunschweig H, Erciyas E, Holzgrabe U. Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with beta-amyloid, acetylcholine, and butyrylcholine esterases. Bioorg Med Chem. 2010; 18(5): 2049-2059.
  • Gwaram NS, Ali HM, Abdulla MA, Buckle MJC, Sukumaran SD, Chung LY, Othman R, Alhadi AA, Yehye WA, Hadi AHA, Hassandarvish P, Khaledi H, Abdelwahab SI. Synthesis, characterization, X-ray crystallography, acetyl cholinesterase inhibition and antioxidant activities of some novel ketone derivatives of gallic hydrazide- derived schiff bases. Molecules. 2012; 17: 2408-2427.
  • Özçelik AB, Gökçe M, Orhan I, Kaynak F, Sahin MF. Synthesis and antimicrobial, acetylcholinesterase and butyrylcholinesterase inhibitory activities of novel ester and hydrazide derivatives of 3(2H)-pyridazinone. Arznei-forschung. 2010; 60(7): 452-458.
  • Bunyapaiboonsri T, Ramström O, Lohmann S, Lehn SM, Peng L, Goeldner M. Dynamic deconvolution of a pre-equilibrated dynamic combinatorial library of acetylcholinesterase inhibitors. Chembiochem. 2001; 2: 438-444.
  • Gholivand K, Hosseini Z, Farshadian S, Naderi-Manesh H. Synthesis, characterization, oxidative degradation, antibacterial activity and acetylcholinesterase/butyrylcholinesterase inhibitory effects of some new phosphorus (V) hydrazides. Eur J Med Chem. 2010; 45(11): 5130- 5139.
  • Elsinghorst PW, Tanarro CMG, Gutschow M. Novel heterobivalent tacrine derivatives as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase. J Med Chem. 2006; 49: 7540-7544.
  • Szymański P, Zurek E, Mikiciuk-Olasik E. New tacrine- hydrazinonicotinamide hybrids as acetylcholinesterase inhibitors of potential interest for the early diagnostics of Alzheimer’s disease. Pharmazie. 2006; 61(4): 269-273.
  • Yale HL, Losen K, Martins J, Holsing M, Perry MF, Bernstein J. Chemotherapy of Experimental Tuberculosis. VIII. The synthesis of acid hydrazides, their derivatives and related compound. J Am Chem Soc. 1953; 75: 1933-1942.
  • Bukowski L, Janowiec M. 1-Methyl-1H-2-imidazo[4,5-b]
  • pyridinecarboxylic acid and of its derivatives with suspected antituberculotic activity. Pharmazie. 1996; 51: 27-30.
  • Kaplancıklı ZA, Turan-Zitouni G, Özdemir A, Revial G. Synthesis and anticandidal activity of some imidazopyridine derivatives. J Enzym Inhib Med Chem. 2008; 23(6): 866-870.
  • Perry NSL, Houghton PJ, Theobald AE, Jenner P, Perry EK. In-vitro inhibition of human erythrocyte acetylcholine esterase by Salvia lavandulae folia essential oil and constituent terpenes. J Pharm Pharmacol. 2000; 52: 895-902.
  • Ellman GL, Courtney KD, Andres V, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961; 7: 88-95.
Toplam 21 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Articles
Yazarlar

Usama Abu Mohsen Bu kişi benim

Yayımlanma Tarihi 30 Ocak 2014
Gönderilme Tarihi 30 Ocak 2014
Yayımlandığı Sayı Yıl 2012 Cilt: 2 Sayı: 3

Kaynak Göster

APA Mohsen, U. A. (2014). Asetilkolinesteraz inhibitörleri olarak imidazopiridin türevleri üzerine çalışmalar. Clinical and Experimental Health Sciences, 2(3), 119-123.
AMA Mohsen UA. Asetilkolinesteraz inhibitörleri olarak imidazopiridin türevleri üzerine çalışmalar. Clinical and Experimental Health Sciences. Şubat 2014;2(3):119-123.
Chicago Mohsen, Usama Abu. “Asetilkolinesteraz inhibitörleri Olarak Imidazopiridin türevleri üzerine çalışmalar”. Clinical and Experimental Health Sciences 2, sy. 3 (Şubat 2014): 119-23.
EndNote Mohsen UA (01 Şubat 2014) Asetilkolinesteraz inhibitörleri olarak imidazopiridin türevleri üzerine çalışmalar. Clinical and Experimental Health Sciences 2 3 119–123.
IEEE U. A. Mohsen, “Asetilkolinesteraz inhibitörleri olarak imidazopiridin türevleri üzerine çalışmalar”, Clinical and Experimental Health Sciences, c. 2, sy. 3, ss. 119–123, 2014.
ISNAD Mohsen, Usama Abu. “Asetilkolinesteraz inhibitörleri Olarak Imidazopiridin türevleri üzerine çalışmalar”. Clinical and Experimental Health Sciences 2/3 (Şubat 2014), 119-123.
JAMA Mohsen UA. Asetilkolinesteraz inhibitörleri olarak imidazopiridin türevleri üzerine çalışmalar. Clinical and Experimental Health Sciences. 2014;2:119–123.
MLA Mohsen, Usama Abu. “Asetilkolinesteraz inhibitörleri Olarak Imidazopiridin türevleri üzerine çalışmalar”. Clinical and Experimental Health Sciences, c. 2, sy. 3, 2014, ss. 119-23.
Vancouver Mohsen UA. Asetilkolinesteraz inhibitörleri olarak imidazopiridin türevleri üzerine çalışmalar. Clinical and Experimental Health Sciences. 2014;2(3):119-23.

14639   14640